Intelligent Medicament Delivery System

Publication ID: 24-11857708_0010_PTD

Published: October 28, 2025

Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Intelligent Medicament Delivery System,” Published Technical Disclosure No. 24-11857708_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857708_0010_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,708.

Summary of the Inventive Concept

An innovative, wearable-based system that combines advanced sensors, AI-driven algorithms, and automated injection technology to revolutionize personalized medicine and injection therapy.

Background and Problem Solved

The original patent, 'Device for attachment to an injection device', addressed the need for a supplementary device to detect and select dosages for injection. However, it had limitations in terms of user convenience, dosage accuracy, and lack of real-time monitoring. The new inventive concept tackles these limitations by introducing a wearable-based system that integrates vital sign detection, AI-driven dosage prediction, and automated injection, enabling more effective and personalized medicine.

Detailed Description of the Inventive Concept

The Intelligent Medicament Delivery System consists of a wearable device that continuously monitors a user's vital signs, such as heart rate, blood pressure, and glucose levels. This data is fed into a neural network-based algorithm that predicts optimal dosages based on the user's medical history and current vital signs. The system then automatically adjusts the dosage and administers the medicament through a microneedle array or pressure-driven injection system. The wearable device also tracks the user's injection history and provides real-time feedback to the user and healthcare professionals.

Novelty and Inventive Step

The new inventive concept introduces a paradigm shift in injection therapy by integrating wearable technology, AI-driven algorithms, and automated injection, thereby providing a more personalized, convenient, and accurate medicament delivery system. The inventive step lies in the combination of these advanced technologies to create a seamless and intelligent system that surpasses the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the Intelligent Medicament Delivery System could include handheld devices with integrated sensors and AI-driven algorithms, or cloud-based platforms that analyze user data and provide personalized recommendations for injection therapy. Variations could also include different types of sensors, algorithms, or injection systems tailored to specific medical conditions or user needs.

Potential Commercial Applications and Market

The Intelligent Medicament Delivery System has vast commercial potential in the healthcare industry, particularly in the fields of diabetes management, pain management, and personalized medicine. The system could be marketed to pharmaceutical companies, healthcare providers, and individual users, offering a more efficient, effective, and convenient way to manage medication and injection therapy.

CPC Classifications

Section	Class	Group
A	A61	A61M5/3155
A	A61	A61M5/2033
A	A61	A61M2005/3126
A	A61	A61M2205/332
A	A61	A61M2205/3327
A	A61	A61M2205/3584
A	A61	A61M2205/52
A	A61	A61M2205/8206

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device technology, specifically drug delivery systems and injection assistance devices, encompassing mechanical interfaces, dosage selection mechanisms, and sensor-integrated medical technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in mechanical engineering, sensor integration, and drug delivery system design, possessing knowledge of electronic control systems, mechanical coupling techniques, and user interface design for medical devices

Obviousness Rationale

A PHOSITA would recognize that the PTD's AI-driven, sensor-integrated injection system represents a predictable technological progression from the source patent's mechanical dosage selection device. The core technical challenge of precise medicament delivery is addressed through incremental improvements in sensing, algorithmic control, and automated injection mechanisms. The integration of neural network algorithms with existing injection device technologies would be considered a logical extension of known medical device design principles.

Obvious Combinations & Variations

Source Patent Element

Mechanical coupling interface for attaching to a drug delivery device's dosage selector

PTD Variation

Wearable device with integrated sensors that dynamically adjust injection parameters based on real-time physiological data

Obviousness Reasoning

Extending mechanical interface concepts to include intelligent sensor integration is a predictable design evolution in medical device technology, representing a known technique of adding computational intelligence to mechanical systems

Source Patent Element

Dial knob for selecting injection dosage

PTD Variation

Neural network-based algorithm for automatically predicting and selecting optimal medicament dosages

Obviousness Reasoning

Transitioning from manual dosage selection to algorithmic dosage determination is an obvious application of machine learning techniques to existing medical device functionality, representing a finite and predictable solution to dosage optimization

Source Patent Element

Supplementary device configured to mechanically interact with injection device

PTD Variation

Wearable system that provides continuous monitoring, injection tracking, and cloud-based data analysis

Obviousness Reasoning

Expanding a supplementary medical device's capabilities to include data tracking and remote monitoring is a known technique in medical technology, representing a logical extension of existing device interaction paradigms

Source Patent Element

Mechanical force transfer mechanism for triggering injection

PTD Variation

Microneedle array and pressure-driven injection system with adaptive skin condition sensing

Obviousness Reasoning

Replacing mechanical injection triggers with advanced microfluidic and sensor-integrated injection mechanisms represents a predictable technological progression in minimally invasive medical device design

35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the variations disclosed in this publication would be considered obvious to a person having ordinary skill in the art at the time of invention, when viewed in light of US Patent 11857708. The incremental technological advancements represent predictable combinations of known medical device design techniques, thereby rendering potential claims covering similar systems unpatentable as obvious variations of the prior art.

Original Patent Information

Patent Number	US 11,857,708
Title	Device for attachment to an injection device
Assignee(s)	Sanofi